Last reviewed · How we verify
dose expansion of SIM0609 in CRC
dose expansion of SIM0609 in CRC is a Small molecule drug developed by Jiangsu Simcere Pharmaceutical Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | dose expansion of SIM0609 in CRC |
|---|---|
| Sponsor | Jiangsu Simcere Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- dose expansion of SIM0609 in CRC CI brief — competitive landscape report
- dose expansion of SIM0609 in CRC updates RSS · CI watch RSS
- Jiangsu Simcere Pharmaceutical Co., Ltd. portfolio CI
Frequently asked questions about dose expansion of SIM0609 in CRC
What is dose expansion of SIM0609 in CRC?
dose expansion of SIM0609 in CRC is a Small molecule drug developed by Jiangsu Simcere Pharmaceutical Co., Ltd..
Who makes dose expansion of SIM0609 in CRC?
dose expansion of SIM0609 in CRC is developed by Jiangsu Simcere Pharmaceutical Co., Ltd. (see full Jiangsu Simcere Pharmaceutical Co., Ltd. pipeline at /company/jiangsu-simcere-pharmaceutical-co-ltd).
What development phase is dose expansion of SIM0609 in CRC in?
dose expansion of SIM0609 in CRC is in Phase 1.